Cibus Inc <CBUS.OQ> expected to post a loss of 69 cents a share - Earnings Preview
Cibus Inc CBUS.OQ CBUS.O is expected to show a rise in quarterly revenue when it reports results on August 14 for the period ending June 30 2025
The San Diego California-based company is expected to report a 36.7% increase in revenue to $1.146 million from $838 thousand a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Cibus Inc is for a loss of 69 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Cibus Inc is $19.25, about 92.7% above its last closing price of $1.40
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.66 | -0.66 | -0.74 | Missed | -12.1 |
Dec. 31 2025 | -0.51 | -0.75 | -0.87 | Missed | -15.2 |
Sep. 30 2024 | -0.89 | -0.89 | 0.06 | Beat | 106.7 |
Jun. 30 2024 | -0.81 | -0.81 | -1.14 | Missed | -40.7 |
Mar. 31 2024 | -1.01 | -1.01 | -1.12 | Missed | -10.9 |
Dec. 31 2023 | -1.43 | -12.59 | Missed | -780.4 | |
Sep. 30 2023 | -1.19 | -1.17 | -1.59 | Missed | -35.9 |
Jun. 30 2023 | -0.30 | -0.30 | -3.05 | Missed | -916.7 |
This summary was machine generated August 12 at 20:48 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.
Investing in Biotech
TradingKey - The biotechnology sector is witnessing a robust rebound led by innovations in genetic science, the technologies of mRNA, drug discovery with the aid of artificial intelligence, and the latest wave of biotech consolidation throughout the sector.
CoreWeave’s Q2 FY2025: AI Surge Drives Record Revenue, but Profit Challenges Persist
TradingKey - CoreWeave, Inc. (NASDAQ: CRWV) Q2 FY2025 earnings delivered strong revenue growth but missed earnings expectations, which led to a roughly 10% stock price drop in after-hours trading. Revenue surged 207% year-over-year, driven by robust demand for its GPU-intensive AI cloud platform.
China July Money Supply Preview: M2 Growth Expected to Remain Elevated
TradingKey - On 15 August 2025, the People's Bank of China will release the July data on broad money supply (M2). The market generally expects that the year-on-year growth rate of M2 in that month will be 8.2%. Although the projected year-on-year growth rate of M2 in July is expected to decrease by
Eurozone Q2 GDP Preview: Euro Losing Momentum, Likely to Enter a Fluctuation Range
TradingKey - On 14 August 2025, the eurozone will release its Q2 GDP data. Market consensus expects that the quarterly growth rate will slow to 0.1% in Q2, down from 0.6% in Q1, which will cause the year-on-year figure to drop by 0.1 percentage points compared to the previous reading.
